Clinical Trial Update: Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer

View source ↗

Summary

A completed clinical trial in metastatic pancreatic cancer analyzes how symptom outcomes and biomarkers relate to overall survival.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer | Status: COMPLETED